Transmural project for subacromial impingement syndrome: a randomized controlled trial comparing a new transmural treatment strategy (TRANSIT) with usual medical care

ISRCTN ISRCTN58108023
DOI https://doi.org/10.1186/ISRCTN58108023
Secondary identifying numbers NL542 (NTR586)
Submission date
04/04/2006
Registration date
04/04/2006
Last edited
20/08/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr O. Dorrestijn
Scientific

University Medical Center Groningen
Department Orthopaedic Surgery
P.O. Box 30.001
Groningen
9700 RB
Netherlands

Phone +31 (0)50 3610078
Email transitonderzoek@gmail.com

Study information

Study designRandomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific titleTransmural project for subacromial impingement syndrome: a randomized controlled trial comparing a new transmural treatment strategy (TRANSIT) with usual medical care
Study acronymTRANSIT
Study objectivesTRANSIT will give patients who have a subacromial impingement syndrome a reduced recovery time, more improvement of arm function and more reduction of shoulder pain compared to patients treated with usual medical care.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSubacromial impingement syndrome
InterventionIntervention group: the treatment is an arthroscopic subacromial decompression performed within six weeks after randomization.
Control group: the treatment is ‘usual medical care’, which consists of treatment in general practice according to the Guidelines for Shoulder Complaints of the Dutch College of General Practitioners (issued in 1999).
Both groups will be followed for one year post-randomization.
Intervention typeOther
Primary outcome measureShoulder Disability Questionnaire: a 16-item measure for functional status limitation in patients with shoulder disorders (Van der Heijden et al, 2000).
Study data will be collected at the following moments: at inclusion, at randomization and three, six and twelve months after randomization.
Secondary outcome measures1. Constant-Murley score - a shoulder-specific scoring system in which patient-reported subjective assessment and objective measurement of shoulder function takes place (Constant et al, 1987)
2. Shoulder Pain Score - a concise questionnaire for the assessment of pain experienced by patients with shoulder complaints (Winters et al, 1996)
3. Shoulder Rating Questionnaire (SRQ-DLV) - a self-administered patient based instrument which assesses shoulder function in seven domains (Vermeulen et al, 2005)
4. Patient-perceived recovery - a one-item score concerning recovery following treatment measured on a seven-point ordinal scale
5. (Dutch) Short-form 36 Health Survey - a Health-related Quality of Life Assessment system composed of 36 questions and standardized response choices, organized into eight multi-item scales (Aaronson, 1998).
6. Cost-effectiveness - an economic evaluation will be performed using a questionnaire for assessment of direct health care costs as well as direct non-health related costs. These data will be used for a cost-effectiveness analysis.
Overall study start date08/03/2006
Completion date01/11/2008

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants70
Key inclusion criteria1. Pain on abduction of the shoulder
2. Shoulder pain as a recurrence of an episode with a maximum duration of 12 months in which a partial or good response is achieved with (a) subacromial corticosteroid injection(s)
3. A maximum duration of three months of shoulder complaints prior to the first subacromial injection, possibly treated with non-steroidal anti-inflammatory drug (NSAID) and/or physiotherapy
4. No shoulder complaints for at least two years prior to the current episode of shoulder pain
5. Men and women, aged between 30 and 60 years
6. Being able to give an informed consent

Amendment to inclusion criterion number 3 as of 24/07/2006:
3. A maximum duration of six months of shoulder complaints prior to the first subacromial injection, possibly treated with non-steroidal anti-inflammatory drug (NSAID) and/or physiotherapy
Key exclusion criteria1. Shoulder girdle pain
2. Shoulder pain not based on pain on abduction of the shoulder
3. Signs of cervical root compression
4. Bilateral shoulder pain
5. Secondary subacromial impingement
6. Presence of specific rheumatic diseases
7. History of severe trauma of the shoulder (fracture or luxation)
8. Previous surgery of the affected shoulder
9. Extrinsic causes of shoulder pain
10. Presence of dementia of other psychiatric disorders
11. Not being able to fill in questionnaires in Dutch
Date of first enrolment08/03/2006
Date of final enrolment01/11/2008

Locations

Countries of recruitment

  • Netherlands

Study participating centre

University Medical Center Groningen
Groningen
9700 RB
Netherlands

Sponsor information

University Medical Center Groningen (UMCG), Department Orthopaedic Surgery (The Netherlands)
Not defined

P.O. Box 30.001
Groningen
9700 RB
Netherlands

ROR logo "ROR" https://ror.org/03cv38k47

Funders

Funder type

University/education

University Medical Center Groningen (UMCG), Health Care Efficiency fund

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article Study protocol: 22/02/2007 Yes No

Editorial Notes

20/08/2021: Proactive update review. No publications found. Search options exhausted.